Botanical extract composition

Details Botanical extract composition Botanical extract composition

2011-01-25

2011-01-25

Mi, Qiuwen (Department: 1655)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

C424S757000, C424S734000, C424S773000, C424S774000, C424S750000

Reexamination Certificate

active

07875298

ABSTRACT:
A kit including a first composition comprising leaves ofMelissa officinalis, or parts thereof; a second composition comprisingEleutherococcus senticosus, or parts thereof; a third composition comprisingAvena sativa, or parts thereof; a fourth composition comprisingBallota nigra, or parts thereof; a third composition comprising the roots ofGlycyrrhiza glabra/gan cao, or parts thereof; and a sixth composition comprising roots ofUncaria tomentosa, or parts thereof. The invention further relates to a kit for use as a medicament, to a kit for use in the treatment of disorders in mammals, like humans, horses, cows, pigs and pets, to a kit for use in the treatment of lupus, multiple sclerosis, rheumatoid arthritis, rheumatism, osteoporosis, asthma in humans or tale and mane eczema in horses, and to the use of the kit for the treatment of lupus, multiple sclerosis, rheumatoid arthritis, rheumatism, osteoporosis, asthma in humans or tale and mane eczema in horses.

REFERENCES:
patent: 6579543 (2003-06-01), McClung
patent: 7087250 (2006-08-01), Marchioni
patent: 2002/0192241 (2002-12-01), Chen et al.
patent: 19853919 (2000-05-01), None
patent: 0270690 (1987-06-01), None
patent: WO 01/34170 (2001-05-01), None
patent: 02/47701 (2002-06-01), None
Flynn, The herbal management of stress, Austrilian journal of medical herbalism, 1996: 8 (1): 15-18.
Widy-Tyszkiewicz et al, A randomized double blind study of sedative effects of phytotherapeutic containing valerian, hops, balm and motherwort versus placebo, Herba polonica, (1997) vol. 43, No. 2, pp. 154-159.
Singh et al, Therapeutic potential of Kava in the treatment of anxiety disorders, CNS drugs 2002: 16 (11): 731-743.
Sandoval, Cat's claw (Uncaria tomentosa) protects against oxidative stress and indomethacin-induced intestinal inflammation, Gastroenterology, 1997; 112 (4 suppl.): A1081.
Disorders from Merck manual, pp. 1-24, accessed on Feb. 17, 2009.
Dementia from Merck manual, pp. 1-3, accessed on Feb. 17, 2009.
Alzheimer's disease from Merck manual, pp. 1-21, accessed on Feb. 17, 2009.
Walker, Personality, coping and sex as psychosocial aspects of psoriatic arthropathy, Dermatology and Psychosomatics, (2003) vol. 4, No. 1, pp. 27-32.
Yu et al, Effects of long-term oral administration of polymeric microcapsules containing tyrosinase on maintaining decreased systemic tyrosine levels in rats, Journal of pharmaceutical sciences, (Apr. 2004) vol. 93, No. 4, pp. 831-837.
Cleaver, Defective repair replication of DNA in xeroderma pig-mentosum, NATURE [London], (1968) vol. 218, No. 5142, pp. 652-656.
Jullien, A new treatment for psoriasis, Nouvelles Dermatologiques, (Apr. 2006) vol. 25, No. 4, pp. 264-272.
Freshney, Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4.
Steinman et al, How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis, Ann Neurol 2006; 60: 12-21.
Sriram et al, Experimental allergic encephalomyeliits: a misleading model of multiple sclerosis, Ann Neurol 2005; 58: 939-945.
Multiple Sclerosis from Merck Manual, accessed on Jul. 15, 2010, pp. 1-6.
Lublin et al, Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology. 1996 46(4): 907-11.
Peizhong et al, Is multiple sclerosis a mitochondrial disease? Biochimica et biophysica acta, (Jan. 2010) vol. 1802, No. 1, pp. 66-79.
Hans-Peter, High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis, Expert opinion on pharmacotherapy, (Feb. 2009) vol. 10, No. 2, pp. 291-309.
Fiske et al, Multiple sclerosis and oral care, Dental update, (Jul.-Aug. 2002) vol. 29, No. 6, pp. 273-283.
Holland et al, Adherence to disease-modifying therapy in multiple sclerosis: Part II, Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses, (Nov.-Dec. 2001) vol. 26, No. 6, pp. 221-226.
“Randomized Double Blind Trial of an Extract from the Pentacyclic Alkaloid-Chemotype of Uncaria Tomentosa for the Treatment of Rheumatoid Arhtritis”. Mur Erich et al. The Journal of Rheumatology, vol. 29, No. 4, pp. 678-681, Apr. 2002.
Database WPI. Section Ch, Week 200262, Derwent Publications Ltd., London, GB, Class B04, AN 2002-581546 XP002305247 & RU 2185182 C2 (Khvostenkov S I) Jul. 20, 2002.
International Search Report (PCT/ISA/210).

Affiliated with

Also associated with

Rating

Botanical extract composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Botanical extract composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Botanical extract composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2728771